HTFL Stock — Heartflow, Inc.

Heartflow, Inc. (HTFL)

Updated October 16, 2026.

HTFL is a Stock. Total return is 154.2% over the past 1.2 years, 131.8 points ahead of SPY at 22.4%.

HeartFlow, Inc. is a medical technology company that develops AI-powered diagnostic solutions for coronary artery disease, using computational fluid dynamics to create personalized 3D heart models from CT scans and analyze blood flow, stenosis, and plaque characteristics. The company does not currently pay distributions. HeartFlow appeals to investors seeking exposure to healthcare innovation and medical device technology rather than dividend income.

HTFL performance versus SPY

Price and return data through 2026-10-16.

Total return is 154.2% over the past 1.2 years, 131.8 points ahead of SPY at 22.4%. Its deepest 1-year drawdown was 48.7%.

HTFL key facts

Asset type

Stock

Asset class

Equity

Inception date

08/07/2025

Distribution frequency

None

Last close

$48.29 (as of 2026-10-16)

Market cap

$4,198,990,648

Average volume

1001668.0

Payout ratio

0.0%

EPS

$-3.16

How Dividend Vision calculates yield and returns

Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

HTFL risks and drawbacks

The deepest 1-year drawdown on record here is 48.7%.

Who may consider HTFL — and who may not

It is a weaker fit for investors who need monthly cash flow (HTFL does not currently distribute). This is educational context, not a recommendation to buy or sell.

More on HTFL

• All tickers starting with H

Tagged: Healthcare.

Frequently asked questions